Industry Research Reports

Home > Reports > Machinery & Equipment > Global Pharma Continuous Granulation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Pharma Continuous Granulation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Machinery & Equipment

Published Date: 2025-03-10

Pages: 94 Pages

Report ld: 4576001

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Pharma Continuous Granulation market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.

The North America Pharma Continuous Granulation market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key manufacturers of Pharma Continuous Granulation include LB Bohle, GEA, LCI, LÖDIGE, Senieer, Thermo Fisher Scientific, Syntegon, Gericke, Bepex, EARTHTECHNICA, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Pharma Continuous Granulation market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

LB Bohle
GEA
LCI
LÖDIGE
Senieer
Thermo Fisher Scientific
Syntegon
Gericke
Bepex
EARTHTECHNICA
Glatt
FREUND
Chansemt

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Dry Method
Wet Method

Segment by Application

Tablets
Capsules
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Pharma Continuous Granulation market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Wet Method in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Capsules in India).

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Pharma Continuous Granulation value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Pharma Continuous Granulation Product Scope

1.2 Pharma Continuous Granulation by Type

1.2.1 Global Pharma Continuous Granulation Sales by Type (2020 & 2024 & 2031)

1.2.2 Dry Method

1.2.3 Wet Method

1.3 Pharma Continuous Granulation by Application

1.3.1 Global Pharma Continuous Granulation Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Tablets

1.3.3 Capsules

1.3.4 Others

1.4 Global Pharma Continuous Granulation Market Estimates and Forecasts (2020-2031)

1.4.1 Global Pharma Continuous Granulation Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Pharma Continuous Granulation Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Pharma Continuous Granulation Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Pharma Continuous Granulation Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Pharma Continuous Granulation Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Pharma Continuous Granulation Sales Market Share by Region (2020-2025)

2.2.2 Global Pharma Continuous Granulation Revenue Market Share by Region (2020-2025)

2.3 Global Pharma Continuous Granulation Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Pharma Continuous Granulation Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Pharma Continuous Granulation Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Pharma Continuous Granulation Market Size and Prospective (2020-2031)

2.4.2 Europe Pharma Continuous Granulation Market Size and Prospective (2020-2031)

2.4.3 China Pharma Continuous Granulation Market Size and Prospective (2020-2031)

2.4.4 Japan Pharma Continuous Granulation Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Pharma Continuous Granulation Historic Market Review by Type (2020-2025)

3.1.1 Global Pharma Continuous Granulation Sales by Type (2020-2025)

3.1.2 Global Pharma Continuous Granulation Revenue by Type (2020-2025)

3.1.3 Global Pharma Continuous Granulation Price by Type (2020-2025)

3.2 Global Pharma Continuous Granulation Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Pharma Continuous Granulation Sales Forecast by Type (2026-2031)

3.2.2 Global Pharma Continuous Granulation Revenue Forecast by Type (2026-2031)

3.2.3 Global Pharma Continuous Granulation Price Forecast by Type (2026-2031)

3.3 Different Types Pharma Continuous Granulation Representative Players

4 Global Market Size by Application

4.1 Global Pharma Continuous Granulation Historic Market Review by Application (2020-2025)

4.1.1 Global Pharma Continuous Granulation Sales by Application (2020-2025)

4.1.2 Global Pharma Continuous Granulation Revenue by Application (2020-2025)

4.1.3 Global Pharma Continuous Granulation Price by Application (2020-2025)

4.2 Global Pharma Continuous Granulation Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Pharma Continuous Granulation Sales Forecast by Application (2026-2031)

4.2.2 Global Pharma Continuous Granulation Revenue Forecast by Application (2026-2031)

4.2.3 Global Pharma Continuous Granulation Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Pharma Continuous Granulation Application

5 Competition Landscape by Players

5.1 Global Pharma Continuous Granulation Sales by Players (2020-2025)

5.2 Global Top Pharma Continuous Granulation Players by Revenue (2020-2025)

5.3 Global Pharma Continuous Granulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Continuous Granulation as of 2024)

5.4 Global Pharma Continuous Granulation Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Pharma Continuous Granulation, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Pharma Continuous Granulation, Product Type & Application

5.7 Global Key Manufacturers of Pharma Continuous Granulation, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Pharma Continuous Granulation Sales by Company

6.1.1.1 North America Pharma Continuous Granulation Sales by Company (2020-2025)

6.1.1.2 North America Pharma Continuous Granulation Revenue by Company (2020-2025)

6.1.2 North America Pharma Continuous Granulation Sales Breakdown by Type (2020-2025)

6.1.3 North America Pharma Continuous Granulation Sales Breakdown by Application (2020-2025)

6.1.4 North America Pharma Continuous Granulation Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Pharma Continuous Granulation Sales by Company

6.2.1.1 Europe Pharma Continuous Granulation Sales by Company (2020-2025)

6.2.1.2 Europe Pharma Continuous Granulation Revenue by Company (2020-2025)

6.2.2 Europe Pharma Continuous Granulation Sales Breakdown by Type (2020-2025)

6.2.3 Europe Pharma Continuous Granulation Sales Breakdown by Application (2020-2025)

6.2.4 Europe Pharma Continuous Granulation Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Pharma Continuous Granulation Sales by Company

6.3.1.1 China Pharma Continuous Granulation Sales by Company (2020-2025)

6.3.1.2 China Pharma Continuous Granulation Revenue by Company (2020-2025)

6.3.2 China Pharma Continuous Granulation Sales Breakdown by Type (2020-2025)

6.3.3 China Pharma Continuous Granulation Sales Breakdown by Application (2020-2025)

6.3.4 China Pharma Continuous Granulation Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Pharma Continuous Granulation Sales by Company

6.4.1.1 Japan Pharma Continuous Granulation Sales by Company (2020-2025)

6.4.1.2 Japan Pharma Continuous Granulation Revenue by Company (2020-2025)

6.4.2 Japan Pharma Continuous Granulation Sales Breakdown by Type (2020-2025)

6.4.3 Japan Pharma Continuous Granulation Sales Breakdown by Application (2020-2025)

6.4.4 Japan Pharma Continuous Granulation Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 LB Bohle

7.1.1 LB Bohle Company Information

7.1.2 LB Bohle Business Overview

7.1.3 LB Bohle Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.1.4 LB Bohle Pharma Continuous Granulation Products Offered

7.1.5 LB Bohle Recent Development

7.2 GEA

7.2.1 GEA Company Information

7.2.2 GEA Business Overview

7.2.3 GEA Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.2.4 GEA Pharma Continuous Granulation Products Offered

7.2.5 GEA Recent Development

7.3 LCI

7.3.1 LCI Company Information

7.3.2 LCI Business Overview

7.3.3 LCI Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.3.4 LCI Pharma Continuous Granulation Products Offered

7.3.5 LCI Recent Development

7.4 LÖDIGE

7.4.1 LÖDIGE Company Information

7.4.2 LÖDIGE Business Overview

7.4.3 LÖDIGE Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.4.4 LÖDIGE Pharma Continuous Granulation Products Offered

7.4.5 LÖDIGE Recent Development

7.5 Senieer

7.5.1 Senieer Company Information

7.5.2 Senieer Business Overview

7.5.3 Senieer Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Senieer Pharma Continuous Granulation Products Offered

7.5.5 Senieer Recent Development

7.6 Thermo Fisher Scientific

7.6.1 Thermo Fisher Scientific Company Information

7.6.2 Thermo Fisher Scientific Business Overview

7.6.3 Thermo Fisher Scientific Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Thermo Fisher Scientific Pharma Continuous Granulation Products Offered

7.6.5 Thermo Fisher Scientific Recent Development

7.7 Syntegon

7.7.1 Syntegon Company Information

7.7.2 Syntegon Business Overview

7.7.3 Syntegon Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Syntegon Pharma Continuous Granulation Products Offered

7.7.5 Syntegon Recent Development

7.8 Gericke

7.8.1 Gericke Company Information

7.8.2 Gericke Business Overview

7.8.3 Gericke Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Gericke Pharma Continuous Granulation Products Offered

7.8.5 Gericke Recent Development

7.9 Bepex

7.9.1 Bepex Company Information

7.9.2 Bepex Business Overview

7.9.3 Bepex Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Bepex Pharma Continuous Granulation Products Offered

7.9.5 Bepex Recent Development

7.10 EARTHTECHNICA

7.10.1 EARTHTECHNICA Company Information

7.10.2 EARTHTECHNICA Business Overview

7.10.3 EARTHTECHNICA Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.10.4 EARTHTECHNICA Pharma Continuous Granulation Products Offered

7.10.5 EARTHTECHNICA Recent Development

7.11 Glatt

7.11.1 Glatt Company Information

7.11.2 Glatt Business Overview

7.11.3 Glatt Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Glatt Pharma Continuous Granulation Products Offered

7.11.5 Glatt Recent Development

7.12 FREUND

7.12.1 FREUND Company Information

7.12.2 FREUND Business Overview

7.12.3 FREUND Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.12.4 FREUND Pharma Continuous Granulation Products Offered

7.12.5 FREUND Recent Development

7.13 Chansemt

7.13.1 Chansemt Company Information

7.13.2 Chansemt Business Overview

7.13.3 Chansemt Pharma Continuous Granulation Sales, Revenue and Gross Margin (2020-2025)

7.13.4 Chansemt Pharma Continuous Granulation Products Offered

7.13.5 Chansemt Recent Development

8 Pharma Continuous Granulation Manufacturing Cost Analysis

8.1 Pharma Continuous Granulation Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Pharma Continuous Granulation

8.4 Pharma Continuous Granulation Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Pharma Continuous Granulation Distributors List

9.3 Pharma Continuous Granulation Customers

10 Pharma Continuous Granulation Market Dynamics

10.1 Pharma Continuous Granulation Industry Trends

10.2 Pharma Continuous Granulation Market Drivers

10.3 Pharma Continuous Granulation Market Challenges

10.4 Pharma Continuous Granulation Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Pharma Continuous Granulation Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Pharma Continuous Granulation Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Pharma Continuous Granulation Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Pharma Continuous Granulation Sales (K Units) by Region (2020-2025)

Table 5. Global Pharma Continuous Granulation Sales Market Share by Region (2020-2025)

Table 6. Global Pharma Continuous Granulation Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Pharma Continuous Granulation Revenue Share by Region (2020-2025)

Table 8. Global Pharma Continuous Granulation Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Pharma Continuous Granulation Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Pharma Continuous Granulation Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Pharma Continuous Granulation Revenue Share Forecast by Region (2026-2031)

Table 12. Global Pharma Continuous Granulation Sales by Type (K Units) & (2020-2025)

Table 13. Global Pharma Continuous Granulation Sales Share by Type (2020-2025)

Table 14. Global Pharma Continuous Granulation Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Pharma Continuous Granulation Price by Type (US$/Unit) & (2020-2025)

Table 16. Global Pharma Continuous Granulation Sales by Type (K Units) & (2026-2031)

Table 17. Global Pharma Continuous Granulation Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Pharma Continuous Granulation Price by Type (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Pharma Continuous Granulation Sales by Application (K Units) & (2020-2025)

Table 21. Global Pharma Continuous Granulation Sales Share by Application (2020-2025)

Table 22. Global Pharma Continuous Granulation Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Pharma Continuous Granulation Price by Application (US$/Unit) & (2020-2025)

Table 24. Global Pharma Continuous Granulation Sales by Application (K Units) & (2026-2031)

Table 25. Global Pharma Continuous Granulation Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Pharma Continuous Granulation Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in Pharma Continuous Granulation Application

Table 28. Global Pharma Continuous Granulation Sales by Company (K Units) & (2020-2025)

Table 29. Global Pharma Continuous Granulation Sales Share by Company (2020-2025)

Table 30. Global Pharma Continuous Granulation Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Pharma Continuous Granulation Revenue Share by Company (2020-2025)

Table 32. Global Pharma Continuous Granulation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Continuous Granulation as of 2024)

Table 33. Global Market Pharma Continuous Granulation Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Pharma Continuous Granulation, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Pharma Continuous Granulation, Product Type & Application

Table 36. Global Key Manufacturers of Pharma Continuous Granulation, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Pharma Continuous Granulation Sales by Company (2020-2025) & (K Units)

Table 39. North America Pharma Continuous Granulation Sales Market Share by Company (2020-2025)

Table 40. North America Pharma Continuous Granulation Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Pharma Continuous Granulation Revenue Market Share by Company (2020-2025)

Table 42. North America Pharma Continuous Granulation Sales by Type (2020-2025) & (K Units)

Table 43. North America Pharma Continuous Granulation Sales Market Share by Type (2020-2025)

Table 44. North America Pharma Continuous Granulation Sales by Application (2020-2025) & (K Units)

Table 45. North America Pharma Continuous Granulation Sales Market Share by Application (2020-2025)

Table 46. Europe Pharma Continuous Granulation Sales by Company (2020-2025) & (K Units)

Table 47. Europe Pharma Continuous Granulation Sales Market Share by Company (2020-2025)

Table 48. Europe Pharma Continuous Granulation Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Pharma Continuous Granulation Revenue Market Share by Company (2020-2025)

Table 50. Europe Pharma Continuous Granulation Sales by Type (2020-2025) & (K Units)

Table 51. Europe Pharma Continuous Granulation Sales Market Share by Type (2020-2025)

Table 52. Europe Pharma Continuous Granulation Sales by Application (2020-2025) & (K Units)

Table 53. Europe Pharma Continuous Granulation Sales Market Share by Application (2020-2025)

Table 54. China Pharma Continuous Granulation Sales by Company (2020-2025) & (K Units)

Table 55. China Pharma Continuous Granulation Sales Market Share by Company (2020-2025)

Table 56. China Pharma Continuous Granulation Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Pharma Continuous Granulation Revenue Market Share by Company (2020-2025)

Table 58. China Pharma Continuous Granulation Sales by Type (2020-2025) & (K Units)

Table 59. China Pharma Continuous Granulation Sales Market Share by Type (2020-2025)

Table 60. China Pharma Continuous Granulation Sales by Application (2020-2025) & (K Units)

Table 61. China Pharma Continuous Granulation Sales Market Share by Application (2020-2025)

Table 62. Japan Pharma Continuous Granulation Sales by Company (2020-2025) & (K Units)

Table 63. Japan Pharma Continuous Granulation Sales Market Share by Company (2020-2025)

Table 64. Japan Pharma Continuous Granulation Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Pharma Continuous Granulation Revenue Market Share by Company (2020-2025)

Table 66. Japan Pharma Continuous Granulation Sales by Type (2020-2025) & (K Units)

Table 67. Japan Pharma Continuous Granulation Sales Market Share by Type (2020-2025)

Table 68. Japan Pharma Continuous Granulation Sales by Application (2020-2025) & (K Units)

Table 69. Japan Pharma Continuous Granulation Sales Market Share by Application (2020-2025)

Table 70. LB Bohle Company Information

Table 71. LB Bohle Description and Business Overview

Table 72. LB Bohle Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. LB Bohle Pharma Continuous Granulation Product

Table 74. LB Bohle Recent Development

Table 75. GEA Company Information

Table 76. GEA Description and Business Overview

Table 77. GEA Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. GEA Pharma Continuous Granulation Product

Table 79. GEA Recent Development

Table 80. LCI Company Information

Table 81. LCI Description and Business Overview

Table 82. LCI Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. LCI Pharma Continuous Granulation Product

Table 84. LCI Recent Development

Table 85. LÖDIGE Company Information

Table 86. LÖDIGE Description and Business Overview

Table 87. LÖDIGE Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. LÖDIGE Pharma Continuous Granulation Product

Table 89. LÖDIGE Recent Development

Table 90. Senieer Company Information

Table 91. Senieer Description and Business Overview

Table 92. Senieer Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Senieer Pharma Continuous Granulation Product

Table 94. Senieer Recent Development

Table 95. Thermo Fisher Scientific Company Information

Table 96. Thermo Fisher Scientific Description and Business Overview

Table 97. Thermo Fisher Scientific Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Thermo Fisher Scientific Pharma Continuous Granulation Product

Table 99. Thermo Fisher Scientific Recent Development

Table 100. Syntegon Company Information

Table 101. Syntegon Description and Business Overview

Table 102. Syntegon Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Syntegon Pharma Continuous Granulation Product

Table 104. Syntegon Recent Development

Table 105. Gericke Company Information

Table 106. Gericke Description and Business Overview

Table 107. Gericke Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Gericke Pharma Continuous Granulation Product

Table 109. Gericke Recent Development

Table 110. Bepex Company Information

Table 111. Bepex Description and Business Overview

Table 112. Bepex Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Bepex Pharma Continuous Granulation Product

Table 114. Bepex Recent Development

Table 115. EARTHTECHNICA Company Information

Table 116. EARTHTECHNICA Description and Business Overview

Table 117. EARTHTECHNICA Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. EARTHTECHNICA Pharma Continuous Granulation Product

Table 119. EARTHTECHNICA Recent Development

Table 120. Glatt Company Information

Table 121. Glatt Description and Business Overview

Table 122. Glatt Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Glatt Pharma Continuous Granulation Product

Table 124. Glatt Recent Development

Table 125. FREUND Company Information

Table 126. FREUND Description and Business Overview

Table 127. FREUND Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. FREUND Pharma Continuous Granulation Product

Table 129. FREUND Recent Development

Table 130. Chansemt Company Information

Table 131. Chansemt Description and Business Overview

Table 132. Chansemt Pharma Continuous Granulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Chansemt Pharma Continuous Granulation Product

Table 134. Chansemt Recent Development

Table 135. Production Base and Market Concentration Rate of Raw Material

Table 136. Key Suppliers of Raw Materials

Table 137. Pharma Continuous Granulation Distributors List

Table 138. Pharma Continuous Granulation Customers List

Table 139. Pharma Continuous Granulation Market Trends

Table 140. Pharma Continuous Granulation Market Drivers

Table 141. Pharma Continuous Granulation Market Challenges

Table 142. Pharma Continuous Granulation Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Pharma Continuous Granulation Product Picture

Figure 2. Global Pharma Continuous Granulation Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Pharma Continuous Granulation Sales Market Share by Type in 2024 & 2031

Figure 4. Dry Method Product Picture

Figure 5. Wet Method Product Picture

Figure 6. Global Pharma Continuous Granulation Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Pharma Continuous Granulation Sales Market Share by Application in 2024 & 2031

Figure 8. Tablets Examples

Figure 9. Capsules Examples

Figure 10. Others Examples

Figure 11. Global Pharma Continuous Granulation Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Pharma Continuous Granulation Sales Growth Rate (2020-2031) & (US$ Million)

Figure 13. Global Pharma Continuous Granulation Sales (K Units) Growth Rate (2020-2031)

Figure 14. Global Pharma Continuous Granulation Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 15. Pharma Continuous Granulation Report Years Considered

Figure 16. Global Market Pharma Continuous Granulation Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 17. Global Pharma Continuous Granulation Revenue Market Share by Region: 2020 VS 2024

Figure 18. North America Pharma Continuous Granulation Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. North America Pharma Continuous Granulation Sales (K Units) Growth Rate (2020-2031)

Figure 20. Europe Pharma Continuous Granulation Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Europe Pharma Continuous Granulation Sales (K Units) Growth Rate (2020-2031)

Figure 22. China Pharma Continuous Granulation Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. China Pharma Continuous Granulation Sales (K Units) Growth Rate (2020-2031)

Figure 24. Japan Pharma Continuous Granulation Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. Japan Pharma Continuous Granulation Sales (K Units) Growth Rate (2020-2031)

Figure 26. Global Pharma Continuous Granulation Revenue Share by Type (2020-2025)

Figure 27. Global Pharma Continuous Granulation Sales Share by Type (2026-2031)

Figure 28. Global Pharma Continuous Granulation Revenue Share by Type (2026-2031)

Figure 29. Global Pharma Continuous Granulation Revenue Share by Application (2020-2025)

Figure 30. Global Pharma Continuous Granulation Revenue Growth Rate by Application in 2020 & 2024

Figure 31. Global Pharma Continuous Granulation Sales Share by Application (2026-2031)

Figure 32. Global Pharma Continuous Granulation Revenue Share by Application (2026-2031)

Figure 33. Global Pharma Continuous Granulation Sales Share by Company (2024)

Figure 34. Global Pharma Continuous Granulation Revenue Share by Company (2024)

Figure 35. Global 5 Largest Pharma Continuous Granulation Players Market Share by Revenue in Pharma Continuous Granulation: 2020 & 2024

Figure 36. Pharma Continuous Granulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 37. Manufacturing Cost Structure of Pharma Continuous Granulation

Figure 38. Manufacturing Process Analysis of Pharma Continuous Granulation

Figure 39. Pharma Continuous Granulation Industrial Chain

Figure 40. Channels of Distribution (Direct Vs Distribution)

Figure 41. Distributors Profiles

Figure 42. Bottom-up and Top-down Approaches for This Report

Figure 43. Data Triangulation

Figure 44. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pharma Continuous Granulation market? zhanKai

The top companies in the global Pharma Continuous Granulation market are LB Bohle、GEA、LCI.

Related Reports

Global Pharma Continuous Granulation Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharma Continuous Granulation market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 158
USD 4900.00
(Single User License)
Global Pharma Continuous Granulation Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharma Continuous Granulation market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 95
USD 4250.00
(Single User License)
Pharma Continuous Granulation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharma Continuous Granulation was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 122
USD 3950.00
(Single User License)
Global Pharma Continuous Granulation Market Research Report 2026
The global Pharma Continuous Granulation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 137
USD 2900.00
(Single User License)
Global Pharma Continuous Granulation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharma Continuous Granulation market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 155
USD 4900.00
(Single User License)
Pharma Continuous Granulation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharma Continuous Granulation was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 112
USD 3950.00
(Single User License)
Global Pharma Continuous Granulation Market Research Report 2025
The global market for Pharma Continuous Granulation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 99
USD 2900.00
(Single User License)
Global and United States Pharma Continuous Granulation Market Report & Forecast 2024-2030
Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
Published Date: 2024-08-11
Pages: 130
USD 4350.00
(Single User License)
Global Pharma Continuous Granulation Market Research Report 2024
Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
Published Date: 2024-08-11
Pages: 105
USD 2900.00
(Single User License)
Global Pharma Continuous Granulation Market Insights, Forecast to 2030
Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
Published Date: 2024-08-11
Pages: 169
USD 4900.00
(Single User License)

Global Pharma Continuous Granulation Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharma Continuous Granulation market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 158
USD 4900.00 (Single User License)
Global Pharma Continuous Granulation Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharma Continuous Granulation market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 95
USD 4250.00 (Single User License)
Pharma Continuous Granulation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharma Continuous Granulation was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 122
USD 3950.00 (Single User License)
Global Pharma Continuous Granulation Market Research Report 2026
The global Pharma Continuous Granulation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 137
USD 2900.00 (Single User License)
Global Pharma Continuous Granulation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharma Continuous Granulation market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 155
USD 4900.00 (Single User License)
Pharma Continuous Granulation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharma Continuous Granulation was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 112
USD 3950.00 (Single User License)
Global Pharma Continuous Granulation Market Research Report 2025
The global market for Pharma Continuous Granulation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 99
USD 2900.00 (Single User License)
Global and United States Pharma Continuous Granulation Market Report & Forecast 2024-2030
Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
Published: 2024-08-11
Pages: 130
USD 4350.00 (Single User License)
Global Pharma Continuous Granulation Market Research Report 2024
Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
Published: 2024-08-11
Pages: 105
USD 2900.00 (Single User License)
Global Pharma Continuous Granulation Market Insights, Forecast to 2030
Pharmaceutical continuous granulation is a process in which the raw material powder is continuously made into particles through a specific process during the pharmaceutical process. This granulation method usually involves multiple steps such as powder mixing, granulation, and drying. All steps are completed in a continuous operation process, rather than in steps like traditional batch granulation. The purpose of pharmaceutical continuous granulation is to improve production efficiency, reduce production costs and improve product quality.
Published: 2024-08-11
Pages: 169
USD 4900.00 (Single User License)